Assessing the health risks of benzene: A report on the benzene state-of-the-science workshop

Journal of Toxicology and Environmental Health - Part A

Volumn 61, Issue 5-6, 2000, Pages 307-338

  Sonawane, B ^f   Snyder, R ^b   Beatty, P ^c   Granville, G ^d   Meek, B ^e  

^a UNIVERSITY OF OTTAWA   (Canada)

^b RUTGERS UNIVERSITY   (United States)

^c CHEVRON ENERGY TECHNOLOGY COMPANY   (United States)

^d SHELL GLOBAL SOLUTIONS INTERNATIONAL B V   (United States)

^e HEALTH CANADA   (Canada)

^f U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZENE; BIOLOGICAL MARKER; PETROLEUM;

BIOLOGICAL MODEL; BLOOD TOXICITY; BONE MARROW TOXICITY; CANCER INCIDENCE; CANCER RISK; CHINA; CONFERENCE PAPER; GENOTOXICITY; HEALTH HAZARD; HUMAN; INDUSTRIAL WORKER; LEUKEMIA; LEUKEMOGENESIS; LYMPHOMA; METABOLISM; MOLECULAR MODEL; MOUSE; MYELODYSPLASTIC SYNDROME; NONHUMAN; OCCUPATIONAL EXPOSURE; OCCUPATIONAL SAFETY; PRIORITY JOURNAL; RISK ASSESSMENT; TRANSGENIC MOUSE;

ANIMALS; BENZENE; BONE MARROW DISEASES; CARCINOGENS; HUMANS; LEUKEMIA; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; RISK ASSESSMENT;

MUS MUSCULUS;

EID: 0033791372     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/00984100050166325     Document Type: Article

References (100)

1. Aksoy, M., Dincol, K., Akgun, T., Erdem, S., and Dincol, G. 1971. Haematological effects of chronic benzene. Br. J. Ind. Med. 28:296-302.
2. 3H benzene. Biochem. Pharmacol. 26: 293-300.
3. Ayres, P. H., and Taylor, W. D. 1989. Solvents. In Principles and methods of toxicology, 2nd ed., ed. A. H. Hayes, pp. 111-135. New York: Raven Press.
4. Barale, R., Marrazzlnl, A., Betti, C., Vangelisti, V., Loprleno, N., and Barrai, I. 1990. Genotoxlclty of two metabolites of benzene: Phenol and hydroquinone show strong synergistic effects in vivo. Mutat. Res. 244:15-20.
5. Bond, G. G., McLaren, E. A., Baldwin, C. L., and Cook, R. R. 1986. An update of mortality among chemical workers exposed to benzene. Br. J. Ind. Med. 43:685-691.
6. Chen, H., and Eastmond, D. A. 1995. Topoisomerase inhibition by phenolic metabolites: A potential mechanism f or benzene's clastogenic effects. Carcinogenesis 16:2301-2307.
7. Crump, K. S. 1994. Risk of benzene-induced leukemia: A sensitivity analysis of the Pliofilm cohort with additional follow-up and new exposure estimates. J. Toxicol. Environ. Health 42:219-242.
8. Dosemeci, M., Li, G.-L., Hayes, R. B., Yin, S. N., Linet, M., Chow, W. H., Wang, Y. Z., Jiang, Z. L., Dai, T. R., Zhang, W. U., Chao, X. J., Ye, P. Z., Kou, Q. R., Fan, Y. H., Zhang, X. C., Lin, X. F., Meng, J. F., Zho, J. S., Wacholder, S., Kneller, R., and Blot, W. J. 1994. A cohort study among workers exposed to benzene in China. II. Exposure assessment. Am. J. Ind. Med. 26:401-411.
9. Eastmond, D. A., Smith, M. T., and Irons, R. D. 1987. An interaction of benzene metabolites reproduces the myelotoxicity observed with benzene exposure. Toxicol. Appl. Pharmacol. 91:85-95.
10. Forni, A., Pacifico, E., and Limonta, A. 1971. Chromosome studies in workers exposed to benzene or toluene or both. Arch. Environ. Health 22:373-378.
11. Gilmour, S., Kalf, G., and Snyder, R. 1986. Characterization and toxicological significance of Phase II enzymes: Comparison of metabolism of benzene and its metabolite phenol in rat liver micro-somes. In Biological reactive intermediates III: Mechanism of action in animal models and human disease, eds. J. J. Kocsis, D. J. Jollow, C. M. Witmer, J. O. Nelson, and R. Snyder, pp. 223-235. New York: Plenum Press.
12. Golomb, H. M., Alimena, G., Rowley, J. D., Vardiman, J. W., Testa, J. R., and Sovik, C. 1982. Correlation of occupation and karyotype in adults with acute nonlymphocytic leukemia. Blood 60:404-411.
13. Goon, D., Matsura, J., and Ross, D. 1993. Metabolism and cytotoxicity of trans, trans-muconaldehyde and its derivatives: Potential markers of benzene ring cleavage reactions. Chem. Biol. Interact. 88:37-53.
14. Greenberg, L., Mayrer, M. R., Goldwater, L., and Smith, A. R. 1939. Benzene (benzol) poisoning in the rotogravure printing industry in New York City. J. Ind. Hyg. Toxicol. 21:395-420.
15. Guy, R. L., Hu, P., Witz, G., and Goldstein, B. D. 1991. Depression of iron uptake into erythrocytes in mice by treatment with the combined benzene metabolites p-benzoquinone, muconalde-hyde, and hydroquinone. J. Appl. Toxicol. 11:443-446.
16. Hamilton-Patterson, J. L., and Browning, E. 1944. Toxic effects in women exposed to industrial rubber solutions. Br. Med. J. 1:349-352.
17. Hayes, R. B., Yin, S. N., Dosemeci, M., Li, G. L., Wacholder, S., Chow, W. H., Rothman, N., Wang, Y. Z., Dai, T. R., Chao, X. J., Jiang, Z. L., Ye, P. Z., Zhao, H. B., Kou, Q. R., Zhang, W. Y., Meng, J. F., Zho, J. S., Lin, X. F., Ding, C. Y., Li, C. Y., Zhang, Z. N., Li, D. G., Travis, L. B., Blot, W. J., and Linet, M. S. 1996. Mortality among benzene-exposed workers in China. Environ. Health Perspect. 104:1349-1352.
18. Hayes, R. B., Yin, S. N., Dosemeci, M., Li, G. L., Wacholder, S., Travis, L. B., Li, C. Y., Rothman, N., Hoover, R. N., and Linet, M. S. 1997. Benzene and the dose-related incidence of hematologic neoplasms in China. JNCI 89:1065-1071.
19. Health Canada. In press. Priority Substance List, Assessment Report. Formaldehyde. Ottawa: Environmental Health Directorate.
20. Helmer, K. J. 1944. Accumulated cases of chronic benzene poisoning in the rubber industry. Acta Med. Scand. 118:254-375.
21. Hughes, K., Meek, M. E., and Bartlett, S. 1994. Evaluation of risks to health from environmental exposure in Canada. J. Environ. Sci. Health C 12:161-172.
22. Inoue, O., Seiji, K., Kasahara, M., Nakatsuka, H., Watanabe, T., Yin, S. G., Li, G. L., Jin, C., Cai, S. X., Wang, X. Z., and Ikeda, M. 1986. Quantitative relation of urinary phenol levels to breath zone benzene concentrations. Br. J. Ind. Med. 43:692-697.
23. Inoue, O., Seiji, K., Kasahara, M., Nakatsuka, H., Watanabe, T., Yin, S. G., Li, G. L., Cai, S. X., Jin, C., and Ikeda, M. 1998a. Determination of catechol and quinol in the urine of workers exposed to benzene. Br. J. Ind. Med. 45:487-492.
24. Inoue, O., Seiji, K., Watanabe, T., Kasahara, M., Nakatsuka, H., Yin, S., Li, G., Cai, S., Jin, C., and Ikeda, M. 1998b. Mutual metabolic suppression between benzene and toluene in man. Int. Arch. Occup. Environ. Health 60:15-20.
25. Jacobs, R. H., Cornbleet, M. A., Vardiman, J. W., Larson, R. A., LeBeau, M. M., and Rowley, J. D. 1986. Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes. Blood 67:1765-1772.
26. Jaques, A. P. 1990. National Inventory of Sources and Emissions of Benzene (1985). Ottawa: Environment Canada, EPS 5/AP/1.
27. Joseph, P., Klein-Szanto, A. J. P., and Jaiswal, A. K. 1998. Hydroquinone causes specific mutations and leads to cellular transformation and in vivo tumorigenesis. Br. J. Cancer78:312-320.
28. Kalf, G. F., and Snyder, R. 1995. A survey of studies on benzene-induced human leukemogenesis. In Update on benzene. Adv. Occup. Med. Rehab. 1:39-67.
29. Kalf, G. F., Renz, J. F., and Nicolescu, R. 1996. p-Benzoquinone, a reactive metabolite of benzene, prevents the processing of pre-interleukins-1a and-1b to active cytokines by inhibition of the processing enzymes, calpain, and interleukin-1converting enzyme. Environ. Health Perspect. 104:1251-1256.
30. Kirk, R. E., Othmer, D. F., Grayson, M., and Eckroth, D. 1983. Kirk-Othmer encyclopedia of chemical technology. New York: John Wiley.
31. Le Beau, M. M., Albain, K. S., Larson, R. A., Vardiman, J. W., Davis, E. M., Blough, R. R., and Golomb, H. M. 1986. Clinical and cytogenetic correlations in 63patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: Further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J. Clin. Oncol. 4:325-345.
32. Li, G. L., Linet, M. S., Hayes, R. B., Yin, S. N., Dosemeci, M., Wang, Y. Z., Chow, W. H., Jiang, Z. L., Wacholder, S., Zhang, W. U., Dai, T. R., Chao, X. J., Zhang, X. C., Ye, P. Z., Kou, Q. R., Meng, J. F., Zho, J. S., Lin, X. F., Ding, C. Y., Wu, C., and Blot, W. J. 1994. Gender differences in hematopoietic and lymphoproliferative disorders and other cancer risks by major occupational group among workers exposed to benzene in China. I. Descriptive findings. J. Occup.Med. 360: 875-881.
33. London, S. J., Lehman, T. A., and Taylor, J. A. 1997. Myeloperoxidase genetic polymorphism in lung cancer risk. Cancer Res. 57:5001-5003.
34. Lovern, M., Turner, M. J., Meyer, M., Kedderis, G. L., Bechtold, W. E., and Schlosser, P. M. 1997. Identification of benzene oxide as a product of benzene metabolism by mouse, rat, and human liver microsomes. Carcinogenesis 18:1695-1700.
35. Low, L. K., Lambert, C. E., and Meeks, J. R. 1995. Tissue-specific metabolism of benzene in zymbal gland and other solid tumor target tissues in rats. J. Am. Coll. Toxicol. 14:40-60.
36. Mathews, J. M., Etheridge, A. S., and Matthews, H. B. 1998. Dose-dependent metabolism of benzene in hamsters, rats and mice. ToxicolSci. 44:14-21.
37. 6]benzene in mice. Cancer Res. 54:4907-4914.
38. Medinsky, M. A., Kenyon, E. M., Seaton, M. J., and Schlosser, P. M. 1996. Mechanistic considerations in benzene physiological model development. Environ. Health Perspect. 104:1399-1404.
39. Niculescu, R., and Kalf, G. F. 1995. A morphological analysis of the short-term effects of benzene on the development of the hematological cells in the bone marrow of mice and the effects of interleukin-1a on the process. Arch. Toxicol. 69:141-148.
40. Paxton, M. B., Chinchilli, V. M., Brett, S. M., and Rodricks, J. V. 1994. Leukemia risk associated with benzene exposure in the Pliofilm cohort. II. Risk estimates. Risk Anal. 14:155-161.
41. Pedersen-Bjergaard, J., and Rowley, J. D. 1994. The balanced and the unbalanced chromosome aberrations of acute myeloid l eukemia may develop in different ways and may contribute differently to malignant t ransformation. Blood 83:2780-2786.
42. Pollini, G., and Colombi, R. 1964. Chromosome damage in lymphocytes during benzene hemopa-thy. Med. J. Lav. 55:641.
43. Rangan, U., and Snyder, R. 1997. Scientific update of benzene. Ann. NY Acad. Sci. 837:105-113.
44. Rao, N. R., and Snyder, R. 1995. Oxidative modifications produced in HL-60 cells on exposure to benzene metabolites. J. Appl. Toxicol. 15:403-409.
45. Raza, A., Gregory, S. A., and Perisler, H. D. 1996. The myelodysplastic syndrome in 1996: Complex stemcell disorders confounded by dual action of cytokines. Leuk. Res. 20:881-890.
46. Reddy, M. V., Schultz, S. C., Blackburn, G. R., and Mackerer, C. R. 1994. Lack of DNA adduct formation in mice treated with benzene. Mutat. Res. 325:149-155.
47. Resegotti, L. 1993. The nature and natural history of myelodysplasia. Hematologia 25:191-204.
48. Rickert, D., Baker, T. S., Bus, J. S., Barrow, C. S., and Irons, R. D. 1979. Benzene disposition in the rat after exposure by inhalation. Toxicol. Appl. Pharmacol. 49:417-423.
49. Rinsky, R. A., Young, R. J., and Smith, A. B. 1981. Leukemia in benzene workers. Am. J. Ind. Med. 2:217-245.
50. Rinsky, R. A., Smith, A. B., Hornung, R., Filloon, T. G., Young, R. J., Okun, A. H., and Landrigan, P. J. 1987. Benzene and leukemia-An epidemiologic risk assessment. N. Engl. J. Med. 316: 1044-1050.
51. Ross, D. 1996. Metabolic basis of benzene toxicity. Eur. J. Haematol. Suppl. 60:111-118.
52. Rothman, N., Li, G. L., Dosemeci, M., Bechtold, W., Marti, G. E., Wang, Y. Z., Linet, M., Xi, L. Q., Lu, W., Smith, M. T., Titenko-Holland, N., Zhang, L. P., Blot, W. J., Yin, S. N., and Hayes, R. B. 1996a. Hematotoxicity among workers heavily exposed to benzene. Am. J. Ind. Med. 29:236-246.
53. Rothman, N., Smith, M. T., Hayes, R. B., Li, G.-L., Irons, R. D., Dosimeci, M., Haas, R., Stillman, M. S., Linet, M., Xi, L.-Q., Bechtold, W. E., Wiemels, J., Campleman, S., Zhang, L., Quintana, P. J. E., Titenko-Holland, N., Wang, W. L., Kolachana, P., Meyer, K. B., and Yin, S. 1996b. An epidemiologic study of early biological effects of benzene in Chinese workers. Environ. Health Perspect. 106:1365-1370.
54. 609C-T mutation and rapid fractional excretion of chlorzoxazone. Cancer Res. 57:2839-2842.
55. Rushton, L., and Romaniuk, H. 1997. A case control study to investigate the risk of leukemia associated with exposure to benzene in petroleum marketing and distribution workers in the United Kingdom. Occup. Environ. Med. 54:152-156.
56. 1mice. Toxicol. Appl. Pharmacol. 94:128-140.
57. 1mice. Toxicol. Appl. Pharmacol. 99:421-444.
58. 14C] benzene by cynomolgus monkeys and chimpanzees. Toxicol. Appl. Pharmacol. 114:277-284.
59. Sammett, D., Lee, E. W., Kocsis, J. J., and Snyder, R. 1979. Partial hepatectomy reduces both metabolism and toxicity of benzene. J. Environ. Health 5:785-792.
60. Sandmeyer, E. E. 1981. Aromatic hydrocarbons. In Patty's industrial hygiene and toxicology, vol. 2, 3rd rev. ed., eds. G. D. Clayton and F. E. Clayton, pp. 3252-3283. New York: Interscience.
61. Savilahti, M. 1956. More than 100 cases of benzene intoxication in a shoe factory. Observations on hematological symptoms and course of the process in one year. Arch. Gewerbepath. Gewerbehyg. 5:147-157.
62. Schlosser, P. M., Bond, J. A., and Medinsky, M. A. 1993. Benzene and phenol metabolism by mouse and rat liver microsomes. Carcinogenesis 14:2477-2486.
63. Schnatter, A. R., Nicolich, M. J., and Bird, M. G. 1996a. Determination of leukemogenic benzene exposure concentrations: Refined analysis of the Pliofilm cohort. Risk Anal. 16:833-840.
64. Schnatter, A. R., Armstrong, T. W., Nicolich, M. J., Thompson, F. S., Katz, A. M., Huebner, W. W., and Pearlman, E. D. 1996b. Lymphohematopoietic malignancies and quantitative estimates of exposure to benzene in Canadian petroleum workers. Occup. Environ. Med. 53:773-781.
65. Schwartz, C., Snyder, R., and Kalf, G. F. 1985. The inhibition of mitochondrial DNA replication in vitro by the metabolites of benzene, hydroquinone, and p-benzo-quinone. Chem. Biol. Interact. 53:327-350.
66. Smith, M. T. 1996. The mechanism of benzene-induced leukemia: A hypothesis and speculations on the causes of leukemia. Environ. Health Perspect. 104:1219-1225.
67. Smith, M. T., and Fanning, E. W. 1997. Modeling chemically-induced leukemia-Implications for benzene risk assessment. Leukocyte Res. 21:105-117.
68. Smith, M. T., and Rothman, N. 1998. Biomarkers of leukemia risk from benzene. In Medical and workplace applications of biomarkers, eds. M. L. Mendelsohn, L. C. Mohr, and J. P. Peeters, pp. 355-374. Washington, DC: Joseph Henry Press, National Academy of Sciences.
69. Smith, M. T., and Zhang, L. 1998. Biomarkers of leukemia risk: Benzene as a model. Environ. Health Perspect. 106:937-946.
70. Smith, M. T., Zhang, L., Wang, Y., Hayes, R. B., Li, G., Wiemels, J., Dosemeci, M., Titenko-Holland, N., Xi, L., Kolchana, P., Yin, S., and Rothman, N. 1998. Increased translocations and anseusomy in chromosomes 8 and 21among workers exposed to benzene. Cancer Res. 58:2176-2181.
71. Smith, T. J., Hammond, S. K., and Wong, O. 1993. Health effects of gasoline exposure I. Exposure assessment for U.S. distribution workers. Environ. Health Perspect. 101:13-21.
72. Snyder, R., and Hedli, C. C. 1996. An overview of benzene metabolism. Environ. Health Perspect. 104:1165-1171.
73. Snyder, R., and Kocsis, J. J. 1975. Current concepts of chronic benzene toxicity. CRC Crit. Rev. Toxicol. 3:265-288.
74. Snyder, R., Dimitriadis, E., Guy, R., Hu, P., Cooper, K. R., Bauer, H., Witz, G., and Goldstein, B. D. 1989. Studies on the mechanism of benzene toxicity. Environ. Health Perspect. 82:31-35.
75. Thirman, M. J., and Larson, R. A. 1996. Therapy-related myeloid leukemia. Hematologic complications of cancer, eds. S. D. Nimer and D. W. Golde. Hematol. Oncol. Clin. North Am. 10:293-320.
76. Ten Berge, W. F., Zwart, A., and Applman, L. M. 1986. Concentration-time mortality response relationship of irritant and systematically acting vapours and gases. J. Hazard. Mater. 13:301-309.
77. Trush, M. A., Twerdok, L. E., Rembish, S. J., Zhu, H., and Li, Y. 1996. Analysis of target cell susceptibility as a basis for the development of a chemoprotective strategy against benzene-induced hematotoxicity. Environ. Health Perspect. 104:1227-1234.
78. Tunek, A., Olofsson, T., and Berlin, M. 1978. Toxic effects of benzene and metabolites on granulopoietic stem cells and bone marrow cellularity in mice. Mol. Pharmacol. 14:920-929.
79. U.S. Department of Health and Human Services, Agency for Toxic Substances and Disease Registry. 1997. Toxicological Profile for Benzene, p 423. Atlanta, GA: Public Health Service.
80. U.S. Environmental Protection Agency. 1979. Final Report on Population Risk to Ambient Benzene Exposures. Prepared by the Carcinogen Assessment Group, Research Triangle Park, NC. EPA/450/ 5-80-004.
81. U.S. Environmental Protection Agency. 1998. Carcinogenic Effects of Benzene: An Update. EPA/600/ P-97/001F. Washington, DC: U.S. EPA.
82. Windholz, M., and Budavari, S. 1983. The Merck index, 10th ed. Rathway, NJ: Merck and Co.
83. Witz, G., Zhang, Z., and Goldstein, B. D. 1996. Reactive ring-opened aldeheyde metabolites in benzene hematotoxicity. Environ. Health Perspect. 104:1195-1199.
84. Wong, O. 1987a. An industry wide mortality study of chemical workers occupationally exposed to benzene. I. General results. Br. J. Ind. Med. 44:365-381.
85. Wong, O. 1987b. An industry wide mortality study of chemical workers occupationally exposed to benzene. I I. Dose response analyses. Br. J. Ind. Med. 44:382-395.
86. Wong, O. 1995. Risk of acute myeloid l eukaemia and multiple myeloma in workers exposed to benzene. Occup. Environ. Med. 52:380-384.
87. Wong, O., and Raabe, G. K. 1989. Critical review of cancer epidemiology in petroleum industry employees, with a quantitative meta-analysis by cancer site. Am. J. Ind. Med. 15:283-310.
88. Wong, O., and Raabe, G. K. 1995. Cell-type-specific leukemia analysis in a combined cohort of more than 208,000 petroleum workers in the United States and the United Kingdom, 1937-1989. Regul. Toxicol. Pharmacol. 21:307-321.
89. Wong, O., and Raabe, G. K. 1997. Multiple myeloma and benzene exposure in a multinational cohort of more than 250,000 petroleum workers. Regul. Toxicol. Pharmacol. 26:188-199.
90. Wong, O., And Raabe, G. K. 1998. Acute myeloid and monocytic leukemia and benzene exposure in petroleum distribution workers in the United Kingdom. Occup. Environ. Med. 55:360-361.
91. Wong, O., Harris, F., and Smith, T. J. 1993. Health effects of gasoline exposure. II. Mortality patterns of distribution workers in the United States. Environ Health Perspect. 101:63-76.
92. Wong, O., Trent, L., and Harris, F. 1999. A nested case-control study of leukemia, multiple myeloma and kidney cancer in a cohort of petroleum workers exposed to gasoline. Occup. Environ. Med. 57:217-221.
93. World Health Organization. 1993. Environmental Health Criteria 150. Benzene, p. 156. Geneva: WHO.
94. Yin, S. N., and Li, G. L. 1986. Epidemiological study on the relationship between benzene and leukemia and other cancer. Chin. J. Ind. Hyg. Occup. Dis. 4:204-207.
95. Yin, S. N., Li, Q., Liu, Y., Tian, F., Du, C., and Jin, C. 1987a. Occupational exposure to benzene in China. Br. J. Ind. Med. 44:192-195.
96. Yin, S. N., Li, G. L., Tain, F. D., Fu, Z. I., Jin, C., Chen, Y. J., Luo, S. J., Ye, P. Z., Zhang, J. Z., Wang, G. C., Wu, H. N., and Zhong, Q. C. 1987b. Leukemia in benzene workers: A retrospective cohort study. Br. J. Ind. Med. 44:124-128.
97. Yin, S. N., Li, G. L., Tain, F. D., Fu, Z. I., Jin, C., Chen, Y. J., Luo, S. J., Ye, P. Z., Zhang, J. Z., Wang, G. C., Zhang, X. C., Wu, H. N., and Zhong, Q. C. 1989. A retrospective cohort study of leukemia and other cancers in benzene. Environ. Health Perspect. 82:207-213.
98. Yin, S. N., Linet, M. S., Hayes, R. B., Li, G. L., Dosemeci, M., Wang, Y. Z., Chow, W. H., Jiang, Z. L., Wacholder, S., Zhang, W. U., Dai, T. R., Chao, X. J., Zhang, X. C., Ye, P. Z., Kou, Q. R., Meng, J. F., Zho, J. S., Lin, X. F., Ding, C. Y., Kneller, R., and Blot, W. J. 1994. Cohort study among workers exposed to benzene in China. I. General methods and resources. Am. J. Ind. Med. 26:383-400.
99. Yin, S. N., Hayes, R. B., Linet, M. S., Li, G. L., Dosemeci, M., Travis, L. B., Li, C. Y., Zhang, Z. N., Li, D. G., Chow, W. H., Wacholder, S., Wang, Y. Z., Jiang, Z. L., Dai, T. R., Zhang, W. Y., Chao, X. J., Ye, P. Z., Kou, Q. R., Zhang, X. C., Lin, X. F., Meng, J. F., Ding, C. Y., Zho, J. S., and Blot, W. J. 1996. A cohort study of cancer among benzene-exposed workers in China: Overall results. Am. J. Ind. Med. 29:227-235.
100. Yoshida, Y., Stephenson, J., and Mufti, G. J. 1993. Myelodysplastic syndromes: From morphology to molecular biology. Part I. Classification, natural history and cell biology of myelodysplasia. Int. J. Hematol. 57:87-97.